132 related articles for article (PubMed ID: 15660574)
1. C-reactive protein and end-stage renal disease.
Lacson E; Levin NW
Semin Dial; 2004; 17(6):438-48. PubMed ID: 15660574
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of C-reactive protein for heart disease in dialysis patients.
Wang AY
Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant?
van der Sande FM; Kooman JP; Leunissen KM
Blood Purif; 2006; 24(4):335-41. PubMed ID: 16557022
[TBL] [Abstract][Full Text] [Related]
4. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein in end-stage renal disease: are there reasons to measure it?
Stenvinkel P; Lindholm B
Blood Purif; 2005; 23(1):72-8. PubMed ID: 15627740
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
[TBL] [Abstract][Full Text] [Related]
8. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
9. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
11. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
12. Predictors of cardiovascular death in ESRD.
Zoccali C; Tripepi G; Mallamaci F
Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.
Kanwar M; Hashem M; Rosman H; Kamalakannan D; Cheema A; Ali A; Gardin J; Maciejko JJ
Am J Cardiol; 2006 Nov; 98(9):1283-7. PubMed ID: 17056347
[TBL] [Abstract][Full Text] [Related]
14. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease.
Arabul M; Gullulu M; Yilmaz Y; Akdag I; Kahvecioglu S; Eren MA; Dilek K
Clin Biochem; 2008 Sep; 41(13):1055-8. PubMed ID: 18571502
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in end-stage renal disease: the hidden enemy.
Stenvinkel P
Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
19. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
[TBL] [Abstract][Full Text] [Related]
20. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
